US FDA News: FDA approves first treatment for chronic rhinosinusitis with nasal polyps

FDA approves Dupixent to treat adults with nasal polyps accompanied by chronic rhinosinusitis or prolonged inflammation of the sinuses and nasal cavity.
Read more: FDA approves first treatment for chronic rhinosinusitis with nasal polyps